MURA-8518

N/A

Report date: 2025/03/17 16:59:26

Base Information

Drug NameMURA-8518
Drug Alias NameMURA-8518
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionInterleukin-18 replacements
TargetsInterleukin 18
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIreland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMural Oncology Inc
China Registration ClassN/A

Develop Information

Active CompaniesMural Oncology Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A